A neurological screening device and method for assessing brain dysfunction of a subject including a projection apparatus configured to project an image onto retinas of a subject, detectors configured to capture light reflected from the retinas, the reflected light indicating a fixation of the eyes, a controller configured to generate baseline cognitive performance data based at least in part on a presence or absence of fixation, cause output of a plurality of assessment images on displays of the neurological screening device, the plurality of assessment images corresponding to a cognitive assessment configured to stress the frontal lobe of the subject, generate stressed cognitive performance data based at least in part on a presence or absence of fixation during the cognitive assessment, and determine brain dysfunction of the subject based at least in part on the baseline cognitive performance data and the stressed cognitive performance data.

A process for more sensitive characterization of tissue composition for generating a quantitative MRI (qMRI) map and corresponding delta analysis. Intervertebral disc degeneration (IVDD), resulting in the depletion of hydrophilic glycosaminoglycans (GAGs) located in the nucleus pulposus (NP), can lead to debilitating neck and back pain. Magnetic Resonance Imaging (MRI) is a promising means of IVD assessment due to the correlation between GAG content and MRI relaxation values. T1 and T2 relaxation data were obtained from healthy cervical IVDs, and relaxation data was modeled using both conventional and stretched exponential (SE) decays. Normalized histograms of the resultant quantitative MRI (qMRI) maps were fit with stable distributions. SE models fit relaxation behavior with lower error compared to monoexponential models, indicating anomalous relaxation behavior in healthy IVDs. SE model parameters T1 and T1 increased with IVD segment, while conventional monoexponential measures did not vary. The improved model fit and correlation between both SE T1 and T1 with IVD level suggests these parameters are more sensitive biomarkers for detection of GAG content variation.

A non-invasive computer-based method and system for assessing a coronary stenosis or other blockage in an artery or other vasculature includes creating a computational model of the vasculature of interest, modeling blood flow through the vasculature, and determining the mean residence time through a given coronary artery segment, which is a direct assessment of physiological changes on the flow of blood as a result of the stenosis. In some embodiments, blood is modeled as a multi-phase fluid.

The present disclosure pertains to delivering sensory stimulation to a subject during a sleep session in order to enhance dream recall. The system may detect REM sleep in the subject during a sleep session based on brain activity of the subject. The system may then deliver sensory stimulation to the subject during the sleep session. The system may deliver sensory stimulation at a frequency in a theta range of an EEG signal in order to increase theta power in the brain activity of the subject. In some embodiments, the system may modulate the intensity of the sensory stimulation according to changes in the EEG theta power associated with the subject during the sleep session. In some embodiments, an increase in EEG theta power associated with the subject may promote dream recall.

An apparatus and method for collecting a breath sample are provided. The apparatus has a breath input interface configured to receive exhaled breath, a first conduit system connected to the breath input interface, a valve configured to control fluid communication between the first conduit system and at least one breath sample storage device configured to store a breath sample, an air circulation system configured to circulate air through the first conduit system upon completion of a first received exhaled breath, and at least one controller configured to control the valve upon completion of the first received exhaled breath at least partially based on a humidity level in the first conduit system.

Systems and methods have been developed for implementation of a breath testing system for convenient sampling of intestinal gases exhaled from a patient's breath. This may include a system with a manifold that includes thermal regulation components, for instance thermistors and resistive heating elements, which maintain the temperature of the gases above the body temperature of the patient. In some examples, the system will determine an indication of whether a patient has SIBO by adjusting a change in exhaled hydrogen concentration by a methane level exhaled by a patient.

An in-vivo implantable electronic device includes a housing, a power reception coil, and an electronic circuit. The housing is formed of a biocompatible material and forms an internal space sealed. The power reception coil is disposed in the internal space of the housing and receives power by interacting with an electromagnetic field formed by an external electric field or magnetic field, or transmits an electromagnetic wave to the outside. The electronic circuit is disposed in the internal space, is connected to the power reception coil, and performs at least processing of an electric signal. The housing includes a first member in a box shape formed of a biocompatible metal material and having an opening, a second member formed of a biocompatible nonmetal material and having a shape that closes the opening, a packing in an annular shape disposed between the first member and the second member.

An in-vivo implantable medical device includes a housing, an electronic circuit component, a power reception coil, and a magnetic material. The housing is formed of a biocompatible material and forms an internal space. The electronic circuit component is disposed in the internal space. The power reception coil is disposed in the internal space, interacts with an external electromagnetic field to form an electromagnetic resonance field to receive power. At least part of a region of the housing in which the electromagnetic resonance field is formed is formed of a biocompatible nonmetal material.

Disclosed is a vertigo diagnosis and treatment system including a frame, a revolution device, a rotation device and a seat, the frame comprising a primary frame and a secondary frame arranged oppositely. The revolution device includes a power mechanism and a slewing frame. The slewing frame is arranged between the primary frame and the secondary frame. The primary frame and the secondary frame provide slewing support for the slewing frame. The rotation device includes a power mechanism and a seat rotating frame. The vertigo diagnosis and treatment system further includes a seat biasing mechanism. Under the combined action of the revolution device and the rotation device, the vertigo diagnosis and treatment system according to the present invention can realize three-dimensional free rotation and hovering in any position, thus achieving vertigo diagnosis and treatment.

A behavior induction system includes an obtaining unit which obtains physiological information of a subject and a non-subject, a communicating unit which communicates with a first device which gives a presentation to induce a behavior of the subject and a second device operated by the non-subject to instruct the first device to give the presentation, and a control unit which controls the first device and/or the second device through the communicating unit based on the obtained physiological information of the subject and the non-subject. The control unit includes an evaluating unit which evaluates mental states of the subject and the non-subject based on the obtained physiological information, and a determining unit which determines control content of the first device and/or the second device based on the evaluation result from the evaluating unit. The communicating unit outputs the control content to the first device and/or the second device.